TechCrunch : OpenAI buys a remote collaboration platform

OpenAI buys a remote collaboration platform

OpenAI is on an M&A tear.

Days after acquiring database tech firm Rockset, OpenAI has purchased Multi (previously Remotion), a startup developing an enterprise-focused, video-first collaboration platform. A source familiar with the matter says that the deal is technically an acqui-hire and that most of Multi’s team — around five people — will join OpenAI following the deal’s close.

Alexander Embiricos, Multi’s CEO and one of its co-founders, says that Multi will shut down after July 24.

“We’re beyond excited to share that Multi is joining OpenAI,” he wrote in a post on Multi’s blog. “Thank you to everybody who used Multi. It was a privilege building with you, and we learned a ton from you.”

With Multi, Embiricos (an ex-Dropbox product manager) and Multi’s second co-founder, Charley Ho (an ex-Google software engineer), set out to build a Zoom-based platform designed for remote teams to work together through video chats. Multi offered features like the ability to collaborate across screen shares from up to 10 people at the same time, customizable shortcuts and automatic deep links for code, designs and documents.


According to Crunchbase data, Multi raised $13 million in cash from VCs including Greylock and First Round Capital prior to Monday’s exit.

As with the Rockset buy, the Multi deal seems to fit into OpenAI’s broader recent strategy of investing heavily in enterprise solutions. OpenAI recently revealed that the corporate tier of its viral AI-powered chatbot platform, ChatGPT, had close to 600,000 users, including 93% of all Fortune 500 firms.

In May, OpenAI signed an agreement with PwC to resell OpenAI’s tools to other businesses. The month before, the company launched a business-oriented custom AI model tuning and consulting program.

The enterprise buys appear to be paying dividends, with OpenAI’s revenue set to eclipse $3.4 billion this year, per The Information.

Along the same vein as OpenAI’s other corporate-aimed product efforts, could we one day see a spruced-up ChatGPT with videoconferencing and remote collaboration capabilities? Maybe. I wouldn’t put it past OpenAI — particularly as the lag time between the org’s flagship models lengthens.

WSJ : Carmakers File Challenge to Parts of New Automatic-Braking Rule

Carmakers File Challenge to Parts of New Automatic-Braking Rule
Industry says using the technology at higher speeds is impractical and too costly; regulators say the move would reduce accidents

A trade group representing carmakers is pushing back on a rule that requires automated emergency-braking systems in future vehicles, arguing the requirements are nearly impossible to meet and would be too costly.

The Alliance for Automotive Innovation, which represents the largest automakers, on Monday petitioned the auto industry’s top safety regulator to reconsider certain parts of the final rule, but it didn’t object to an overall requirement that new vehicles come equipped with the automatic-braking feature.

The move by automakers marks the latest clash between the industry and safety regulators, who have tried to impose stricter standards and take advantage of new technologies to reduce traffic deaths after a rise in recent years.

Automatic-braking systems use sensors, cameras and software to detect potential crashes with other vehicles and pedestrians, automatically applying the brakes if the driver fails to do so.

Carmakers voluntarily agreed in 2016 to increase offerings of the braking systems by 2025, but government officials have pushed for higher standards for the technology given inconsistencies between different systems. About 90% of new light vehicles made in 2022 were built with the technology, according to regulators.

The National Highway Traffic Safety Administration completed the rule in late April, requiring all vehicles sold in 2029 to come with the auto-braking technology. It mandates certain standards for the systems, such as being able to stop and avoid contact with another vehicle traveling at as much as 62 miles an hour and being able to detect pedestrians in darkness.

The new regulations also would require cars be able to apply the brakes automatically at as much as 90 mph when a vehicle collision is imminent, and at as much as 45 mph before a possible collision with a pedestrian.

NHTSA has said the requirement would slash rear-end accidents and pedestrian crashes, saving at least 360 lives a year and preventing at least 24,000 injuries.

John Bozzella, president of the Alliance for Automotive Innovation, said in a letter to Congress on Monday that the rule would require systems to work at higher speeds than are practical with current technology. He also said NHTSA’s requirements would cause vehicles to apply brakes well before what other drivers expect, leading to more rear-end collisions.

NHTSA didn’t immediately respond to a request for comment.

Bozzella added that regulators had underestimated the costly changes needed to comply with the new rule, which would lead to higher car prices for consumers.

“Yes, this rule will make vehicles more expensive, but the real issue isn’t cost—it’s cost/benefit,” he said. NHTSA’s rule, he added, “will require more costly systems that won’t improve driver or pedestrian safety.”

The technology has caused issues for some consumers in the past. Regulators in recent years have investigated incidents in which the technology activates for no apparent reason, at times leading to crashes.

Regulators have pushed for increased use of automatic braking as they crack down on full self-driving technologies. NHTSA is investigating Tesla’s automatic-driving features, which were linked to a spate of injuries and fatalities.

WSJ : Airbus to Miss Plane-Delivery Annual Goals, Citing Technical Challenges

Airbus to Miss Plane-Delivery Annual Goals, Citing Technical Challenges
The European plane maker said that it will book charges of about €900 million in the first half of 2024

Airbus AIR 0.13%increase; green up pointing triangle said it won’t be meeting its annual targets for the year, including the number of commercial aircraft it planned to deliver, after its space-systems management team identified further commercial and technical challenges.

The European plane maker on Monday said that it will also book charges of about €900 million ($962.5 million) in the first half of 2024 following an extensive review of its space-systems programs.

Airbus expects to end the year delivering 770 commercial aircraft, down from a prior outlook of 800 commercial aircraft deliveries a couple of months ago.

The company said its A320 ramp-up trajectory has been adjusted to reflect specific supply-chain challenges in a degraded operating environment, and that its target production rate of 75 A320 Family aircraft a month is now set to be reached a year later, in 2027.

Airbus also forecasts adjusted earnings before interest and taxes of about €5.5 billion, below the €6.5 billion to €7 billion expected previously.

Airbus’s free cash flow before customer financing expectations have also been lowered to €3.5 billion from €4 billion, the company said.

The first-half expenses are mainly related to updated assumptions on schedules, workload, sourcing, risks and costs over the lifetime of certain telecommunications, navigation and observation programs, Airbus said.

Airbus’ first-half results are set to be published on July 30.

FT : Novo Nordisk invests $4bn to expand weight loss drug production in US

Novo Nordisk invests $4bn to expand weight loss drug production in US
Danish pharma group plans 1.4mn sq ft manufacturing plant in North Carolina to help meet surging demand

Novo Nordisk is investing $4.1bn to expand its US manufacturing and boost production of its blockbuster weight-loss drugs to meet surging demand.

The Danish pharma group said on Monday that the investment will fund a new 1.4mn sq ft manufacturing plant on a site near Raleigh, North Carolina, doubling its size. The extra capacity will come online between 2027 and 2029.

The investment comes as Novo Nordisk competes with rival Eli Lilly for a larger share of the market for a new class of diabetes and weight loss drugs, known as GLP-1s, which is already set to generate $42bn in sales this year and is projected to reach as much as $130bn by 2030.

Both Novo Nordisk’s Wegovy weight loss drug and its Ozempic diabetes treatment, as well as Eli Lilly’s rival Zepbound and Mounjaro medicines have been hit by shortages in recent months, according to the US Food and Drug Administration.

Both companies have spent billions of dollars to increase production of their drugs, which are self administered with an injection pen. Novo Nordisk this year agreed to pay $11bn for three “fill and finish” sites owned by Catalent, as part of a deal between the US contract drug manufacturer and Novo Nordisk’s parent company Novo Holdings.

As part of the “fill and finish” process, drugs are formulated before being filtered into syringes.

Including the latest investment, Novo Nordisk has committed $6.8bn this year to boost its own in-house production capacity. Last year, it announced plans to spend $6.5bn on a new Danish manufacturing site to increase production of semaglutide, the active ingredient used in its weight loss drugs.

Eli Lilly last month announced plans to spend $5.3bn on a manufacturing site to make tirzepatide, the compound behind its weight loss drugs, in its home state of Indiana. Since 2020, Eli Lilly has spent $18bn on building manufacturing operations across five sites in the US and Europe.

Lars Fruergaard Jørgensen, Novo Nordisk’s chief executive, said the investment was “yet another real signal of our efforts to scale up our production to meet the growing global need for our life-changing medicines”. The North Carolina facility will also help produce drugs targeting other chronic diseases.

Novo Nordisk has enough “fill and finish” capacity to manufacture roughly 850mn of the injectable pens for all of its diabetes and weight loss drugs this year, according to industry estimates seen by the Financial Times.

Booming demand for weight loss drugs has made Novo Nordisk Europe’s most valuable company, with a market capitalisation of $636bn as of Monday afternoon.

The new manufacturing site, located in the North Carolina town of Clayton, will create 1,000 new jobs in addition to the 2,500 people who already work for the group in the area. Novo Nordisk has had a presence in Clayton since 1993.

FT : Man accused of directing savers to UK ‘Ponzi scheme’ hit by asset freezing

Man accused of directing savers to UK ‘Ponzi scheme’ hit by asset freezing order
Paul Careless alleged to have received £12mn from collapsed ‘minibond’ provider London Capital & Finance

An ex-police officer who is accused of netting about £12mn by directing members of the public in the UK to an alleged “Ponzi scheme” is to be hit by a freezing order on his property.

A High Court judge on Monday said he would impose asset restrictions on Paul Careless, who is accused of being a main beneficiary of one of the UK’s biggest retail savings scandals in recent years.

Careless is among a group of individuals being sued by administrators to the failed financial services firm London Capital & Finance. Almost 12,000 individual investors were promised high returns through “minibonds” offered by LCF, but lost a total of £237mn when it collapsed in 2019.

Victims had been directed to LCF by Surge Financial, an online marketing company established by Careless that received commissions of 25 per cent for each referral. The claimants have alleged Careless himself netted about £11.9mn.

Administrators have described LCF as “a Ponzi scheme”, and said that while the firm purported to use the funds raised to provide much-needed finance to small and medium-sized enterprises, those it had lent to were not independent but were connected with people behind the firm.

Careless has previously denied the claims against him, and said he had no knowledge of impropriety.

The judge, Mr Justice Miles, is yet to rule on the merits of the underlying case, which concluded this month. But he said on Monday that he would grant a request made by the administrators to restrict how Careless can use proceeds from the sale of his property in the Cotswolds, estimated to be worth about £2.25mn.

Administrators called on the judge to order that the cash be frozen and not used to cover the former police officer’s legal expenses, which the court heard had reached about £2mn.

Stephen Robins KC, for the administrators, told the court that there was “obviously a risk of serious, and possibly irremediable, prejudice” to the administrators “if, at the close of a long fraud trial, [Careless] is permitted to dissipate the proceeds of sale of his largest identifiable asset”.

The judge said he recognised that the order could be “tough” on Careless’s solicitors, who had “agreed to act on credit, and now find themselves in the unfortunate position of not being able to be paid”.

The claimants’ application for a freezing order was granted in principle, although court officials said the final wording was yet to be finalised.

The judge added there was “very substantial evidence” about the “very large amounts of money” received by Careless, and it was unclear what had happened to it.

A ruling in the case is expected in coming months.

FT : Adnoc’s long Covestro chase set to achieve Europe’s largest

Adnoc’s long Covestro chase set to achieve Europe’s largest takeover of year

UAE oil company’s lengthy courtship and sweetened €14.4bn bid key to overcoming German chemical group’s reluctance

Sheikh Mohammed bin Zayed al-Nahyan, president of the United Arab Emirates, returned from last week’s Eid al-Adha holiday to find a request in his in-tray.

Could Abu Dhabi’s national oil company Adnoc bump up its offer for Covestro, one of Germany’s largest companies, by just €2 per share or 3 per cent?

Sheikh Mohammed obliged, closing in on a potential €14.4bn deal including debt after more than 12 months of on-off negotiations that would make it Europe’s biggest takeover this year, the largest cash-deal in the chemical industry and the first big takeover of a Dax 40 company by a Gulf state.

For Adnoc, the €62-a-share deal — a premium of nearly 60 per cent on the German group’s share price last June before news of the initial talks — is part of a five-year, $150bn plan to transform itself from a traditional state-owned oil company into an international energy giant.

After doing a string of smaller deals, in particular for gas assets, Covestro is a tent-pole acquisition that the oil company can proudly present to Sheikh Mohammed at its November strategy day.

One person with knowledge of the negotiations said the lengthy courtship had been essential to overcoming the nervousness of the German company.

“Sometimes these things just have to be digested by both sides. You need to reach the right trust level and if you rush it, then you might never get there,” they said. “Especially the German side needed to understand what Adnoc’s objectives are, because it is not like a private equity firm or a strategic buyer who slashes costs.”

The final negotiations could be wrapped up soon, as many of Adnoc’s questions have already been answered by Covestro ahead of formal due diligence, one person said.

Covestro, spun out of pharma company Bayer in 2015, is a market leader in producing the chemicals used to make foam insulation and speciality plastics. The footballs in this year’s Euro 2024 championships are printed with Covestro’s coatings. 

“It is smack in the middle of some [climate] transition megatrends,” said the person with knowledge of the negotiations. “They are leading in forms of foam insulation — and insulating buildings is growing above GDP growth. Polycarbonates are lightweight speciality engineering plastics, which are used to replace metals with lighter weights, for example in battery casings for the electric vehicle industry.” 

A large part of its business was in Asia and in the US, they added. “They are not just tied to the German automotive industry and the construction industry. They are much more diversified.”

But Covestro’s share price peaked in 2018 at €95 and had fallen to under €40 before Adnoc started its pursuit. Since then it has risen to €53.86, its Monday close.

More recently the German company has suffered from higher energy prices and their impact on its European industrial customers, as well as from competition from China. At its last results presentation, Covestro said that while its sales volumes had increased, its prices had dropped. 

Analysts at TD Cowen said in a note that fair value for Covestro’s shares was €41.20 and added that “considering the stagnant earnings at Covestro in the last year” and the slim prospect of recovery, it was unclear what strategy the management would have presented at its capital markets day on Thursday this week, which was cancelled after the deal announcement. 

But analysts at Barclays and Citi both have price targets of €61 a share on the stock, and Kepler has €65. At its first-quarter results in April, Covestro said it had turned a corner and was forecasting earnings before interest, tax, depreciation and amortisation (Ebitda) for this year of between €1bn and €1.6bn.

Sebastian Bray, head of chemicals research at Berenberg, said the deal was a way for Adnoc to expand “by targeting a good-quality asset that has not done that well operationally in the last two years due to weak demand and [high] European energy prices”.

Covestro’s 20 per cent fall in sales in 2023 to €14.4bn and negative net income left expansion out of the question. Under the cash-rich ownership of Adnoc, the company is likely to have more access to capital for growth.

“A $10bn market cap is not very large for a global company,” said the person close to the deal. “You have to make sure you are always pre-empting the next cycle and not overextending yourself with the next €2bn project.” 

People close to Adnoc stressed that if a deal goes through, Covestro will be managed independently and allowed to pursue its growth strategy, as well as its focus on sustainability. “There is obviously a firm belief in both the management team, their credentials, experience and the growth trajectory of this company,” they said.

Covestro is trying to transition away from its heavy dependence on feedstocks derived from oil, and is experimenting with ways of recycling and breaking down plastics back into raw materials so that it can reuse them. 

Asked how ownership by a huge oil company fitted with Covestro’s sustainability efforts, the company’s chief financial officer Christian Baier told the German business magazine Wirtschaftswoche in May: “One thing is clear: sustainability is the core of our strategy.”

The people close to Adnoc pointed to synergies with the company’s other petrochemical company Borouge, which is also experimenting with recycling plastics.

Other points for negotiation will include commitments to Covestro’s unions over its 17,500-strong workforce, which was trimmed by 500 people last year, and on whether jobs are preserved in Germany as the company grows further in the US and Asia.